Matthew Young Overview

  • Primary Position
  • Managing Directo...

  • Primary Industry
  • Healthcare

  • Active Board Seats
  • 3

  • Med. Deal Size

  • Med. Valuation

Matthew Young General Information

Biography

Mr. Matthew Young serves as Managing Director at Longitude Capital. Mr. Young serves as Board Member at OrsoBio and CytomX Therapeutics. He serves as the Chief Financial Officer & Senior Vice President at Jazz Pharmaceuticals. From February 2009 to April 2013, Mr. Young served as a managing director in the global healthcare of Barclays Capital Inc., an investment banking firm, where his role included acting as the co-head of life sciences at Barclays Capital. From 2007 to 2008, Mr. Young served as a managing director of Citigroup Global Markets Inc., an investment banking firm, and from 2003 to 2007, as a managing director of Lehman Brothers Inc., an investment banking firm. From 1992 to 2003, Mr. Young served in various capacities at other investment banking firms. In 2015, he joined the board of directors of PRA Health Sciences, Inc., a contract research company. He is also a member of the board of directors and chairman of the audit committee of CytomX Therapeutics, Inc., a biopharmaceutical company. Mr. Young received a B.S. in Economics and an M.B.A. from the Wharton School of the University of Pennsylvania.

Contact Information

Primary Position
Managing Director, Longitude Capital
Education
University of Pennsylvania (Wharton), MBA (Master of Business Administration)
University of Pennsylvania (Wharton), BS (Bachelor of Science)
Gender
Male
Email
my
Phone
+1 (650)
Address
  • 2740 Sand Hill Road
  • 2nd Floor
  • Menlo Park, CA 94025
  • United States
+1 (650)

Matthew Young Positions (1)

Firm name Firm type Title Location Industry Since
Longitude Capital Investor Managing Director Menlo Park, CA Venture Capital

Matthew Young Board Seats (3)

Company Industry Ownership Status Financing Status Location Since
Alpha-9 Oncology Biotechnology Privately Held (backing) Venture Capital-Backed Boston, MA
CytomX Therapeutics Biotechnology Publicly Held Formerly VC-backed South San Francisco, CA
OrsoBio Biotechnology Privately Held (backing) Venture Capital-Backed Menlo Park, CA

Matthew Young Lead Partner on Deals (2)

Matthew Young has been the lead partner on 2 deals. Their latest deal was with Alpha-9 Oncology, a biotechnology company. The deal was made for on 23-Oct-2024.

Company Deal Date Deal Type Deal Size Deal Status Industry Location
Alpha-9 Oncology 23-Oct-2024 Later Stage VC (Series C) Completed Biotechnology Boston, MA
OrsoBio 28-Aug-2024 Completed Biotechnology Menlo Park, CA

Matthew Young Network (56)

Board Members (44)

Name Company Representing Location From
Max Lin PRA Health Sciences Kohlberg Kravis Roberts Raleigh, NC
Steven Stein MD Alpha-9 Oncology Self Boston, MA
Avenge Bio Longitude Capital Natick, MA
PRA Health Sciences Kohlberg Kravis Roberts Raleigh, NC
Alpha-9 Oncology Ascenta Capital Boston, MA

Portfolio Executives (12)

Name Company Role Deal date Location
David Hirsch Ph.D Alpha-9 Oncology Chief Executive Officer & Board Member 23-Oct-2024 Boston, MA
Ovid Trifan Ph.D Alpha-9 Oncology Chief Medical Officer 23-Oct-2024 Boston, MA
Alpha-9 Oncology Senior Director of Business Development and Strategy 23-Oct-2024 Boston, MA
Alpha-9 Oncology Chief Executive Officer 23-Oct-2024 Boston, MA
Alpha-9 Oncology Chief Operating Officer 23-Oct-2024 Boston, MA

Matthew Young FAQs

  • Who is Matthew Young?

    Mr. Matthew Young serves as Managing Director at Longitude Capital.

  • How much does Matthew Young typically invest?

    Matthew Young's median deal size is .

  • What is Matthew Young’s main position?

    Matthew Young’s primary position is Managing Director.

  • What are the contact details for Matthew Young?

    Matthew Young’s email address is my and his phone number is +1 (650) .

  • How many active board seats does Matthew Young hold?

    Matthew Young holds 3 board seats including Alpha-9 Oncology, CytomX Therapeutics, and OrsoBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »